Walker v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided December 30, 2019·No. 16-543·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS

********************* SAHARA WALKER, * * No. 16-543V * Special Master Christian J. Moran Petitioner, * v. * * Filed: December 2, 2019 SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Attorneys’ fees and costs, interim Respondent. * award *********************

Andrew D. Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for Petitioner; Sarah C. Duncan, United States Dep’t of Justice, Washington, D.C., for Respondent.

UNPUBLISHED DECISION AWARDING ATTORNEYS’ FEES AND COSTS ON AN INTERIM BASIS1

On May 3, 2016, Melissa Roglitz-Walker, on behalf of her daughter Sahara Walker (“Petitioner”), filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa–10 through 34 (2012). Petitioner claims that she suffered from neurocardiogenic syncope, postural orthostatic tachycardia syndrome (“POTS”), orthostatic hypotension, and autonomic neuropathy, after receiving the tetanus-diphtheria-acellular pertussis (“Tdap”), meningococcal conjugate (“MCV”), and Gardasil (human papillomavirus (“HPV”)) vaccines on September 25, 2013. Pet., filed May 3, 2016, at 1-2. Petitioner’s counsel of record is Mr. Andrew Downing.

1 The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services), requires that the Court post this decision on its website. This posting will make the decision available to anyone with the internet. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special master will appear in the document posted on the website. On August 11, 2016, the Secretary argued that compensation was not appropriate because petitioner failed to establish a diagnosis of autonomic neuropathy; has not offered a viable scientific or medical theory establishing that the vaccines she received can cause any of her alleged injuries or that they did so in her particular case; and has not presented viable scientific or medical evidence to show an onset that would allow for an inference of causation-in-fact. Resp’t’s Rep. at 21-22. The Secretary also argued that petitioner has failed to provide a report of a medical expert to support her claim, and that she has ignored potential alternative causes. Id. at 23.

To develop her case, petitioner filed an expert report from Dr. Gireesh Velugubanti who was later terminated due to disciplinary actions coming to light, after which petitioner filed expert reports from Dr. Jill Schofield, Dr. Mitchell Miglis, and Dr. Lawrence Steinman. Exhibits 32, 47, 89, 118. In rebuttal, the Secretary filed reports from two experts, Dr. Andrew MacGinnitie and Dr. Horacio Kaufmann. Exhibits A, C.

On August 22, 2019, petitioner moved for an award of attorneys’ fees and costs on an interim basis, requesting $106,882.00 in fees and $24,606.55 in costs, for a total of $131,488.55. Pet’r’s Mot. IAFC at 3, 7. For the reasons that follow, petitioner is awarded $125,021.05.

* * *

The requested fees include work performed and costs incurred as of August 22, 2019, when petitioner filed her motion. Petitioner argues that an award of interim fees and costs is appropriate in this case because: (1) petitioner’s submission of medical records and expert reports satisfy the reasonable basis requirement, Pet’r’s Mot. IAFC at 1-2; (2) expenses sought are significant and above the threshold requirements, id. at 3; and (3) it will likely be a significant time period before the case concludes given that a hearing will likely not occur for at least a year and no progress toward settlement has occurred, id. at 2.

The Secretary filed his response to petitioner’s motion on September 5, 2019. Resp’t’s Resp. The Secretary did not provide any objection to petitioner’s request. Id. Instead, he stated that he “defers to the Special Master to determine whether or not petitioner has met both the legal standard for an interim fees and costs award as set forth in Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343 (Fed. Cir. 2008).” Id. at 2.

2 This matter is now ripe for adjudication.

Petitioner’s motion implicitly raises a series of sequential questions, each of which requires an affirmative answer to the previous question. First, whether petitioner is eligible under the Vaccine Act to receive an award of attorneys’ fees and costs? Second, whether, as a matter of discretion, petitioner should be awarded his attorneys’ fees and costs on an interim basis? Third, what is a reasonable amount of attorneys’ fees and costs? These questions are addressed below.

1. Eligibility for an Award of Attorneys’ Fees and Costs

As an initial matter, interim fee awards are available in Vaccine Act cases. Avera, 515 F.3d at 1352. Since petitioner has not received compensation from the Program, he may be awarded “compensation to cover [his] reasonable attorneys’ fees and other costs incurred in any proceeding on such petition if the special master or court determines that the petition was brought in good faith and there was a reasonable basis for the claim.” 42 U.S.C. § 300aa-15(e)(1). As the Federal Circuit has stated, “good faith” and “reasonable basis” are two separate elements that must be met for a petitioner to be eligible for attorneys’ fees and costs. Simmons v. Sec’y of Health & Human Servs., 875 F.3d 632, 635 (Fed. Cir. 2017).

“Good faith” is a subjective standard. Id.; Hamrick v. Sec’y of Health & Human Servs., No. 99-683V, 2007 WL 4793152, at *3 (Fed. Cl. Spec. Mstr. Nov. 19, 2007). A petitioner acts in “good faith” if he or she honestly believes that a vaccine injury occurred. Turner v. Sec’y of Health & Human Servs., No. 99-544V, 2007 WL 4410030, at * 5 (Fed. Cl. Spec. Mstr. Nov. 30, 2007). The Secretary has not challenged petitioner’s good faith here, and there is little doubt that petitioner brought the claim with an honest belief that a vaccine injury occurred.

In contrast to good faith, reasonable basis is purely an objective evaluation of the weight of the evidence. Simmons, 875 F.3d at 636. Because evidence is “objective,” the Federal Circuit’s description is consistent with viewing the reasonable basis standard as creating a test that petitioners meet by submitting evidence. See Chuisano v. Secʼy of Health & Human Servs., No. 07-452V, 2013 WL 6234660 at *12–13 (Fed. Cl. Spec. Mstr. Oct. 25, 2013) (explaining that

3 reasonable basis is met with evidence), mot. for rev. denied, 116 Fed. Cl. 276 (2014).

Here, the reports from the experts petitioner has retained, Dr. Schofield, Dr. Miglis, and Dr. Steinman, satisfy the reasonable basis standard. See Exhibits 47, 89, 118. These reports, combined with petitioner’s medical records, establish a theory of causation and provide a reasonable basis sufficient for the attorneys’ fees and costs determination.

2. Appropriateness of an Interim Award

Interim awards should not be awarded as a matter of right. Avera, 515 F.3d at 1352 (Fed. Cir. 2008). Instead, petitioners must demonstrate “undue hardship.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Walker v. Secretary of Health and Human Services, (uscfc 2019).

Walker v. Secretary of Health and Human Services (Walker v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related